Autoimmune haemolytic anaemias (AIHAs) are well-characterized disorders. They can be differentiated from one another and from other non-immune haemolytic anaemias by clinical, laboratory and serological testing. However, several misleading clinical presentations and/or serological findings may result in misinterpretation, delay and/or misdiagnosis. Such failures are avoidable by adequate clinical and serological experience of the responsible physicians and serologists or, at least, by an optimised bidirectional communication. As long as this has not been achieved, unpleasant failures are to be expected. A true diagnosis of AIHA can neither be verified by clinical nor serological findings alone. Thus, a collective clinical and serological picture remains obligatory for fulfilling the criteria of optimal diagnosis and therapy. Ultimately, the majority of pioneer scientific and practical work in this field stems from scientists who were simultaneously involved in both the clinic and serology.

1.
Dacie J: The Haemolytic Anaemias. Vol. 3. The Auto-Immune Haemolytic Anaemias. New York, Churchill Livingstone, 1992.
2.
Salama A, Ahrens N, Kiesewetter H: Serological and clinical aspects of autoimmune hemolytic anemias. Infus Ther Med 2002;29:206-217.
3.
Petz LD, Garraty G: Immune Hemolytic Anemias, 2nd ed. Philadelphia, Churchill Livingstone, 2004.
4.
Michel M: Classification and therapeutic approaches in autoimmune hemolytic anemia: an update. Expert Rev Hematol 2011;4:607-618.
5.
Bass GF, Tuscano ET, Tuscano JM: Diagnosis and classification of autoimmune hemolytic anemia. Autoimmun Rev 2014;13:560-564.
6.
Gilliland BC: Coombs-negative immune hemolytic anemia. Semin Hematol 1976;13:267-275.
7.
Salama A, Mueller-Eckhardt C, Bhakdi S: A two-stage immunoradiometric assay with 125I-staphylococcal protein A for the detection of antibodies and complement on human blood cells. Vox Sang 1985;48:239-245.
8.
Sokol RJ, Booker DJ, Stamps R, Jalihal S, Paul B: Direct Coombs test-negative autoimmune hemolytic anemia and low-affinity IgG class antibodies. Immunohematology 1997;13:115-118.
9.
Garratty G: Immune hemolytic anemia associated with negative routine serology. Semin Hematol 2005;42:156-164.
10.
Barcellini W, Revelli N, Imperiali FG, Villa MA, Manera MC, Paccapelo C, Zaninoni A, Zanella A: Comparison of traditional methods and mitogen-stimulated direct antiglobulin test for detection of anti-red blood cell autoimmunity. Int J Hematol. 2010;91:762-769.
11.
Fayek MH, Saad AA, Eissa DG, Tawfik LM, Kamal G: Role of gel test and flow cytometry in diagnosis of Coombs' negative autoimmune haemolytic anaemia. Int J Lab Hematol 2012;34:311-319.
12.
Segel GB, Lichtman MA: Direct antiglobulin (‘Coombs') test-negative autoimmune hemolytic anemia: a review. Blood Cells Mol Dis 2014;52:152-160.
13.
Bloch EM, Sakac D, Branch HA, Cserti-Gazdewich C, Pendergrast J, Pavenski K, Branch DR: Western immunoblotting as a new tool for investigating direct antiglobulin test-negative autoimmune hemolytic anemias. Transfusion 2015;55:1529-1537.
14.
Barcellini W: Pitfalls in the diagnosis of autoimmune haemolytic anaemia. Blood Transfus 2015;13:3-5.
15.
Göttsche B, Salama A, Mueller-Eckhardt C: Autoimmune hemolytic anemia associated with an IgA autoanti-Gerbich. Vox Sang 1990;58:211-214.
16.
Sachs UJ, Röder L, Santoso S, Bein G: Does a negative direct antiglobulin test exclude warm autoimmune haemolytic anaemia? A prospective study of 504 cases. Br J Haematol 2006;132:655-656.
17.
Panzer S, Salama A, Bödeker RH, Mueller-Eckhardt C: Quantitative evaluation of elution methods for red cell antibodies. Vox Sang 1984;46:330-335.
18.
Torloni AS, McCullough JS, Brecher ME, Tribble LJ, Hill MG: Microwave elution of red cell antibodies. Vox Sang 1994;66:276-279.
19.
Caruccio L, Byrne K, Procter J, Stroncek D: A novel method using formamide for the elution of antibodies from erythrocytes. Vox Sang 2002;83:63-69.
20.
Garratty G, Arndt P: Applications of flow cytofluorometry to transfusion science. Transfusion 1995;35:157-178.
21.
Zimring JC, Cadwell CM, Spitalnik SL: Antigen loss from antibody-coated red blood cells. Transfus Med Rev 2009;23:189-204.
22.
Sümnig A, Mayer B, Kiefel V, Greinacher A, Salama A: ‘Chameleonic' serological findings leading to life-threatening haemolytic transfusion reactions. Transfus Med Hemother 2015; DOI: 10.1159/000437198.
23.
Salama A, Mueller-Eckhardt C: Autoimmune haemolytic anaemia in childhood associated with non-complement binding IgM autoantibodies. Br J Haematol 1987;65:67-71.
24.
Garratty G: The significance of IgG on the red cell surface. Transfus Med Rev 1987;1:47-57.
25.
Bove JR, Holburn AM, Mollison PL: Non-specific binding of IgG to antibody-coated red cells. (the ‘Matuhasi-Ogata phenomenon'). Immunology 1973;25:793-801.
26.
Quinti I, Pulvirenti F, Milito C, Granata G, Giovannetti G, La Marra F, Pesce AM, Farrugia A, Coluzzi S, Girelli G: Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment. Transfusion 2015;55:1067-1074.
27.
Salama A: Drug-induced immune hemolytic anemia. Expert Opin Drug Saf 2009;8:73-79.
28.
Salama A, Mayer B: Diagnostic pitfalls of drug-induced immune hemolytic anemia. Immunohematology. 2014; 30(2):80-4.
29.
Garratty G, Arndt P: Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007. Immunohematology 2014;30:66-79.
30.
Hoppe B, Stibbe W, Bielefeld A, Pruss A, Salama A: Increased RBC autoantibody production in pregnancy. Transfusion 2001;41:1559-1561.
31.
Sürücü G, Yürek S, Mayer B, Salama A: Pregnancy-induced autoantibodies to red blood cells. Transfus Med Hemother 2015; DOI: 10.1159/000440672.
32.
Salama A, Mueller-Eckhardt C: Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells. Transfusion 1984;24:188-193.
33.
Ahrens N, Pruss A, Kähne A, Kiesewetter H, Salama A: Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion. Transfusion 2007;47:813-816.
34.
Zimring JC, Spitalnik SL, Roback JD, Hillyer CD: Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis. Transfusion 2007;47:2189-2196.
35.
Yürek S, Almahallawi M, Mayer B, Pruss A, Salama A: Precautions surrounding blood transfusion in autoimmune haemolytic anemias are overestimated. Blood Transfus 2015; doi: 10.2450/2015.0326-14.
36.
Bartolmäs T, Mayer B, Yürek S, Genth R, Salama A: Paradoxical findings in direct antiglobulin test and classification of agglutinating autoantibodies using eluates and monospecific anti-human globulin sera. Vox Sang 2015;108:58-63.
37.
Freedman J: The significance of complement on the red cell surface. Transfus Med Rev 1987;1:58-70.
38.
Berentsen S, Sundic T: Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy. Biomed Res Int 2015;2015:363278.
39.
Salama A, Mueller-Eckhardt C: Binding of fluid phase C3b to nonsensitized bystander human red cells. A model for in vivo effects of complement activation on blood cells. Transfusion 1985;25:528-534.
40.
Salama A, Hugo F, Heinrich D, Höge R, Müller R, Kiefel V, Mueller-Eckhardt C, Bhakdi S: Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass. N Engl J Med 1988;318:408-414.
41.
Salama A, Bhakdi S, Mueller-Eckhardt C: Evidence suggesting the occurrence of C3-independent intravascular immune hemolysis. Reactive hemolysis in vivo. Transfusion 1987;27:49-53.
42.
Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F, Younger JG, Drouin SM, Wetsel RA, Ward PA: Generation of C5a in the absence of C3:a new complement activation pathway. Nat Med 2006;12:682-687.
43.
Parker CJ: The pathophysiology of paroxysmal nocturnal hemoglobinuria. Exp Hematol 2007;35:523-533.
44.
Rachidi S, Musallam KM, Taher AT: A closer look at paroxysmal nocturnal hemoglobinuria. Eur J Intern Med 2010;21:260-267.
45.
Salama A: Immunreaktionen gegen Erythrozyten; in Kiefel V (Hrsg): Transfusionsmedizin und Immunhämatologie, 4. Aufl. Heidelberg, Springer 2010, pp 79-89.
46.
Salama A, Janvier D, Mayer B, Saison C, Moscatelli H, Aucouturier F, Yilmaz P, Arnaud L, Wild V, Knop S, Cartron JP: Lethal autoimmune hemagglutination due to an immunoglobulin A autoagglutinin with band 3 specificity. Transfusion 2014;54:1988-1995.
47.
Göttsche B, Salama A, Mueller-Eckhardt C: Donath-Landsteiner autoimmune hemolytic anemia in children. A study of 22 cases. Vox Sang 1990;58:281-286.
48.
Jones TE, Ayrton AS, Blajchman MA: Anomalous ABO grouping due to a new serum factor reactive with a reagent coloring material. Transfusion 1973;13:150-152.
49.
Hysell JK, Gray JM, Hysell JW, Beck ML: An anti-neomycin antibody interfering with ABO grouping and antibody screening. Transfusion 1975;15:16-22.
50.
Vengelen-Tyler V, Dearolf SJ, Haley S: Two examples of antibodies dependent upon the presence of inosine. Transfusion 1981;21:315-319.
51.
Howe SE, Sciotto CG, Berkner D: The role of carboxylic acids in EDTA-dependent panagglutination. Transfusion 1982;22:111-114.
52.
Shulman IA. Hasz LA, Simpson RB: Thimerosal dependent agglutination, a newly described blood bank problem. Transfusion 1982;22:241-243.
53.
Shulman IA, Simpson RB, Farmer CF, Lam H-T: Thimerosal-dependent agglutination complicating the serologic evaluation for unexpected antibodies. Transfusion 1984;24:365-367.
54.
Mason JM, Osborne PT, Hall AJ, Skolnik JS, Woods LL, Wood CL, Pierce SR, Beck ML: Example of a thimerosal-dependent antibody without apparent blood group specificity. Vox Sang 1985;48:313-316.
55.
Yasuda H, Ohto H, Motoki R, Uchikawa M: An EDTA-associated anti-B agglutinin: the role of ionized calcium. Transfusion 1997;37:1131-1136.
56.
Joshi SR: Citrate-dependent auto-antibody causing error in blood grouping. Vox Sang 1997;72:229-232.
57.
Seltsam A, Hell A, Heymann G, Salama A: Donor-derived alloantibodies and passenger lymphocyte syndrome in two of four patients who received different organs from the same donor. Transfusion 2001;41:365-370.
58.
Petz, LD: Immune hemolysis associated with transplantation. Semin Hematol 2005;42:145-155.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.